To determine the role of glucagon and glucagon-related peptides in type 2 diabetes, and whether hyperproglucagonaemia exists independently of obesity, MASLD and type 2 diabetes, we analysed data from the UK Biobank including data from nearly 500,000 individuals. The gene discussed is GCG; the disease is obesity disorder.